Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humalog Mix25 versus Humalog Mix50 crossover study in type 2 diabetes
ChiCTR-TTRCC-12002516Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin lispro mix25 and insulin lispro + insulin lispro protamine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Mean amplitude of glycemic excursion. Started Nov 2012; status: completed.
02
Drugs
insulin lispro mix25insulin lispro + insulin lispro protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TTRCC-12002516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-12002516.